Sensitivity of Stromal Elements from Human Bone Marrow Cells to Cytosine Arabinoside In Vitro
Cytosine arabinoside (Ara-C) is one of the most effective agents in the treatment of acute myelogenous leukemia (AML). Recently, low-dose Ara-C therapy has been the subject of topical interest in view of its differentiation-inducing effect on leukemic blast cells. Many patients, however, develop severe aplasia with low-dose Ara-C therapy [1, 6, 10, 11]. The aim of our study was to obtain some information about causes of this aplasia, i.e., to determine whether the lesion is primarily in the hemopoietic stem cells or whether there is any additional damage done to stromal elements.
KeywordsAgar Leukemia Heparin Anemia Oncol
Unable to display preview. Download preview PDF.
- 1.Degos L, Castaigne S, Tilly H, Sigaux F, Daniel MT (1985) Treatment of leukemia with low-dose Ara-C. A study of 160 cases. Semin Oncol [Suppl 3] 12(2):196–199Google Scholar
- 3.Elstner E, Schulze E, Ihle R, Stobbe H, Grunze S (1985) Stromal progenitor cells in bone marrow of patients with aplastic anemia. In: Neth R, Gallo R, Greaves MF, Janka G (eds) Haematology and blood transfusion. Springer, Berlin Heidelberg New York Tokyo, pp 168–171 (Modern trends in human leukemia 6)Google Scholar